Gregory T. Wurz Department of Internal Medicine, Division of Hematology and Oncology University of California, Davis Biography Publications Institution JoVE Articles Gregory T. Wurz has not added a biography. If you are Gregory T. Wurz and would like to personalize this page please email our Author Liaison for assistance. Publications Ospemifene for the Treatment of Dyspareunia Associated with Vulvar and Vaginal Atrophy: Potential Benefits in Bone and Breast International Journal of Women's Health. 2013 | Pubmed ID: 24109197 Antitumor Effects of L-BLP25 Antigen-Specific Tumor Immunotherapy in a Novel Human MUC1 Transgenic Lung Cancer Mouse Model Journal of Translational Medicine. Mar, 2013 | Pubmed ID: 23496860 Ospemifene, Vulvovaginal Atrophy, and Breast Cancer Maturitas. Jan, 2013 | Pubmed ID: 23332519 L-BLP25 Vaccine Plus Letrozole for Breast Cancer: Is Translation Possible? Oncoimmunology. Nov, 2012 | Pubmed ID: 23243615 L-BLP25 Vaccine Plus Letrozole Induces a TH1 Immune Response and Has Additive Antitumor Activity in MUC1-expressing Mammary Tumors in Mice Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. May, 2012 | Pubmed ID: 22434666 Ospemifene and 4-hydroxyospemifene Effectively Prevent and Treat Breast Cancer in the MTag.Tg Transgenic Mouse Model Menopause (New York, N.Y.). Jan, 2012 | Pubmed ID: 21926925 Pharmacologic Effects of Ospemifene in Rhesus Macaques: a Pilot Study Basic & Clinical Pharmacology & Toxicology. Jun, 2008 | Pubmed ID: 18346046 Ineffectiveness of American Ginseng in the Prevention of Dimethylbenzanthracene-induced Mammary Tumors in Mice Oncology Research. 2006 | Pubmed ID: 17476970 Selective Estrogen Receptor Modulators Inhibit Growth and Progression of Premalignant Lesions in a Mouse Model of Ductal Carcinoma in Situ Breast Cancer Research : BCR. 2005 | Pubmed ID: 16280035 Ospemifene Inhibits the Growth of Dimethylbenzanthracene-induced Mammary Tumors in Sencar Mice The Journal of Steroid Biochemistry and Molecular Biology. Nov, 2005 | Pubmed ID: 16153821 Pharmacokinetics of Selective Estrogen Receptor Modulators Clinical Pharmacokinetics. 2003 | Pubmed ID: 12648026 SERMs: Current Status and Future Trends Critical Reviews in Oncology/hematology. Jul, 2002 | Pubmed ID: 12098608 Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development Daniel P. Vang1, Gregory T. Wurz1, Stephen M. Griffey2, Chiao-Jung Kao1, Audrey M. Gutierrez1, Gregory K. Hanson1, Michael Wolf3, Michael W. DeGregorio1 1Department of Internal Medicine, Division of Hematology and Oncology, University of California, Davis, 2Comparative Pathology Laboratory, UC Davis School of Veterinary Medicine, University of California, Davis, 3Merck Serono Research, Merck KGaA, Darmstadt, Germany JoVE 50868 Médecine
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development Daniel P. Vang1, Gregory T. Wurz1, Stephen M. Griffey2, Chiao-Jung Kao1, Audrey M. Gutierrez1, Gregory K. Hanson1, Michael Wolf3, Michael W. DeGregorio1 1Department of Internal Medicine, Division of Hematology and Oncology, University of California, Davis, 2Comparative Pathology Laboratory, UC Davis School of Veterinary Medicine, University of California, Davis, 3Merck Serono Research, Merck KGaA, Darmstadt, Germany JoVE 50868 Médecine